• SB-505124 Hydrochloride in Mechanobiology

  2026-08-17

  SB-505124 hydrochloride is a reversible ALK4/5/7 inhibitor for separating TGF-β signaling from cancer-cell mechanics. This guide translates the MRTFA–KCNMB1 findings into rigorous assay design, with practical controls for fibrosis, mechanobiology, and metastasis research.

• Elbasvir and Grazoprevir for Hepatitis C: Evidence Review

  2026-08-17

  This evidence-focused review examines how complementary NS5A and NS3/4A inhibition supports effective treatment of HCV genotype 1 and 4 infections. It also explains the pharmacologic, clinical, resistance, safety, and special-population findings synthesized by Wang, Huang, and Yu, with practical guidance for translating the evidence into research workflows.

• Simvastatin (Zocor): Lipid and Cancer Workflows

  2026-08-16

  Build reproducible HepG2 lipid-disorder, cholesterol, and hepatic cancer assays with Simvastatin (Zocor) as a mechanistically defined benchmark. This guide connects practical dosing, lipidomics, apoptosis, and troubleshooting strategies while distinguishing literature-backed conditions from optimization starting points.

• PP 3: A Better Control for Src Assays

  2026-08-15

  PP 3, or 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine, is a research use only chemical for separating Src-dependent effects from downstream calcium-channel mechanisms. This guide translates vascular ROS findings into a practical control strategy for rigorous kinase assays.

• O-GlcNAcylation Rewires Wnt-Driven Bone Formation

  2026-08-14

  The reference study identifies O-GlcNAcylation as a metabolic and post-translational mechanism that enables Wnt3a-driven osteoblastogenesis. Its central finding is that Wnt3a modifies PDK1 at Ser174, stabilizing PDK1 and redirecting glucose toward aerobic glycolysis, thereby supporting bone formation and fracture healing.

• Z-VDVAD-FMK: Apoptosis or Pyroptosis?

  2026-08-14

  Z-VDVAD-FMK is an irreversible, cell-permeable inhibitor for dissecting caspase-2-linked apoptosis. This guide explains how to use it alongside mitochondrial, proteolytic, and pyroptosis readouts to avoid misinterpreting persistent cell death in cancer research.

• Isoproterenol Sulfate Dihydrate: Lab Guide

  2026-08-13

  This scenario-based guide shows how Isoproterenol sulfate dihydrate (SKU C6402) can improve experimental control in beta-adrenergic, viability, proliferation, and human pacemaker-model workflows. It connects formulation, storage, dosing, and data interpretation to current SAN-plexus assembloid research.

• Isoproterenol Sulfate Dihydrate in SAN Assays

  2026-08-13

  Use Isoproterenol sulfate dihydrate as a controlled beta-adrenergic challenge to separate intrinsic pacemaker behavior from neural modulation in human PSC-derived cardiac assembloids. The workflow combines dose-response analysis, cAMP/PKA pathway readouts, and electrophysiology for practical cardiovascular research.

• EZ Cap Cy5 Firefly Luciferase mRNA Guide

  2026-08-12

  EZ Cap Cy5 Firefly Luciferase mRNA combines a Cap1-capped, 5-moUTP modified mRNA transcript with covalent Cy5 labeling and Firefly Luciferase expression. The design separates delivery tracking by fluorescence from functional translation readout by bioluminescence, while product specifications define a 1921-nucleotide transcript supplied at 1 mg/mL.

• Liproxstatin-1 Workflows for Ferroptosis Research

  2026-08-12

  Build more discriminating ferroptosis assays with Liproxstatin-1 as a pathway-focused rescue control rather than a general cytoprotectant. This guide connects GPX4-deficient cell protection, lipid-peroxidation imaging, renal injury models, and a carefully bounded extension into Candida albicans research.

• PNU 74654: Strategic Wnt Pathway Inhibition

  2026-08-11

  A translational framework for using PNU 74654 to interrogate Wnt/β-catenin biology, informed by evidence on the WNT5a/GSK3/β-catenin axis in muscle progenitors. The article distinguishes mechanistic rationale from direct validation, outlines practical assay design, and positions this Wnt signaling pathway inhibitor for disciplined cancer and stem cell research.

• Deferoxamine (DeferoxamineB) in Cell Assays

  2026-08-11

  Learn how Deferoxamine (DeferoxamineB), SKU BA2746, can improve experimental control in viability, proliferation, and regulated cell-death studies. This scenario-based guide connects iron chelation, assay compatibility, solution preparation, interpretation, and practical product-selection criteria.

• Malate in Metabolic-Immune Assay Design

  2026-08-10

  Malate and (S)-2-hydroxysuccinic acid are more than TCA cycle markers: they can help structure experiments linking mitochondrial redox, metabolic flux, and immune signaling. This guide translates recent PDHA1 succinylation findings into practical assay decisions while clearly separating established biology from testable malate-based hypotheses.

• Isoproterenol sulfate dihydrate in SAN assays

  2026-08-09

  Use Isoproterenol sulfate dihydrate as a controlled beta-adrenergic challenge in human PSC-derived sinoatrial node and cardiac plexus assembloids. This workflow connects acute cAMP/PKA pathway responses with pacemaker maturation, neural modulation, and reproducible cardiovascular research rather than treating agonist sensitivity as a standalone endpoint.

• Grazoprevir Hydrate: From Target to Regimen

  2026-08-08

  Grazoprevir hydrate, also known as MK-5172 hydrate, is examined from molecular target through clinical regimen design. This evidence-led guide connects hepatitis C virus replication inhibition with genotype, resistance, comorbidity, pharmacokinetic, and assay decisions.

8537 records 8/570 page Previous Next First page 上5页 678910 下5页 Last page